logo

Biogen Inc. (BIIB)



Trade BIIB now with
  Date
  Headline
5/3/2022 7:16:47 AM Biogen Q1 GAAP EPS $2.06; Non-GAAP EPS $3.62
5/2/2022 6:36:06 AM Sage Therapeutics, Biogen Begin Rolling Submission Of NDA To US FDA For Zuranolone For Potential Treatment Of MDD
3/30/2022 7:46:04 AM Biogen Submits Final Protocol For ADUHELM Phase 4 ENVISION Trial To FDA
3/28/2022 7:34:53 AM Biogen : Phase 1 Study Of BIIB078 On Amyotrophic Lateral Sclerosis Did Not Meet Any Secondary Efficacy Endpoints
3/16/2022 7:40:48 AM Biogen Inc. Announces Data From Long-term Extension Study Of ADUHELM
2/3/2022 7:05:25 AM Biogen Q4 EPS $2.50; Non-GAAP EPS $3.39
1/31/2022 7:34:14 AM Biogen Announces Nancy Leaming And Brian Posner To Retire From Board